Drug Mart Stool Softener plus Stimulant Laxative 50 mg/1
Docusate sodium, Sennosides · TABLET · Discount Drug Mart, Inc
Drug Mart Stool Softener plus Stimulant Laxative is a tablet containing docusate sodium, sennosides at 50 mg/1, taken oral. Manufactured by Discount Drug Mart, Inc.
Key Facts
- Brand Name
- Drug Mart Stool Softener plus Stimulant Laxative
- Generic Name
- Docusate sodium, Sennosides
- NDC Code (Product)
53943-154- Manufacturer
- Discount Drug Mart, Inc
- Strength
- 50 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- M007
- Marketing Start
- 07/20/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Drug Mart Stool Softener plus Stimulant Laxative used for?
Drug Mart Stool Softener plus Stimulant Laxative contains Docusate sodium, Sennosides. It is a tablet taken oral. Consult your doctor for specific uses.
Is Drug Mart Stool Softener plus Stimulant Laxative a controlled substance?
Drug Mart Stool Softener plus Stimulant Laxative is not classified as a controlled substance by the DEA.
What is the generic name for Drug Mart Stool Softener plus Stimulant Laxative?
The generic name for Drug Mart Stool Softener plus Stimulant Laxative is Docusate sodium, Sennosides. There are 11 other brand versions of Docusate sodium, Sennosides.
What is the NDC code for Drug Mart Stool Softener plus Stimulant Laxative 50 mg/1?
The NDC (National Drug Code) for Drug Mart Stool Softener plus Stimulant Laxative 50 mg/1 is 53943-154, listed by Discount Drug Mart, Inc.
Other Docusate Brands
See all →- Laxative Stool Softener50 mg/169842-776
- Drug Mart Vegetable Laxative plus Stool Softener50 mg/153943-153
- Sool Softener Laxative50 mg/149035-270
- Senna S50 mg/10363-1173
- Senna Plus50 mg/169842-883
- Laxative and Stool Softener50 mg/149035-360
- Sankaijo8.33 mg/149873-404
- Senna S50 mg/183059-0120
- CVS Health Stool Softener Plus stimulant laxative Softgel50 mg/151316-318
- Senna-S50 mg/163561-0187
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)